Basket cover image
15 handpicked stocks

Nuclear Renaissance

Looking to invest in the future of clean, reliable energy? These carefully selected stocks represent companies driving the comeback of nuclear power. From uranium miners to cutting-edge reactor designers, our experts have assembled the key players in this growing sector.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at juin 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

CCJ

Cameco Corporation

CCJ

Current price

$73.82

A leading global producer of uranium fuel, essential for reactor operation.

SMR

NuScale Power Corp

SMR

Current price

$32.65

A pioneer in developing small modular reactor (SMR) technology for scalable, clean power generation.

UEC

Uranium Energy Corp.

UEC

Current price

$9.66

Operates a hub-and-spoke platform of in-situ recovery uranium projects in the United States.

About This Group of Stocks

1

Our Expert Thinking

Nuclear energy stands at a critical crossroads as nations seek reliable, carbon-free power sources. We've assembled companies across the entire nuclear value chain - from uranium producers to innovative reactor developers - that are positioned to benefit from renewed government support and growing electricity demands, particularly from AI infrastructure.

2

What You Need to Know

This collection offers exposure to the complete nuclear lifecycle. The portfolio balances established uranium producers with next-generation technology developers creating small modular reactors (SMRs). These stocks represent a growth-oriented component that could complement a diversified energy investment strategy.

3

Why These Stocks

These companies were selected for their strategic positioning within the nuclear revival. We've included industry leaders in uranium production, fuel enrichment specialists, and pioneers developing safer, more scalable nuclear solutions. Each company plays a vital role in ensuring nuclear's place in the clean energy transition.

Group Performance Snapshot

11 of 12

Stocks Rated Buy by Analysts

11 of 12 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

Power Grid Revolution

Nuclear is gaining renewed support as governments seek reliable, carbon-free energy solutions that can support increasingly electrified economies and power-hungry AI data centers.

🔋

Beyond Solar and Wind

While other renewable investments get headlines, nuclear provides the steady baseload power that grids need 24/7, regardless of weather. This fundamental advantage is driving fresh investment and innovation.

🚀

Next-Gen Technology Leap

Small modular reactors are reimagining nuclear power with safer, faster-to-build designs that could unlock massive market potential. Several companies in this group are leading this transformation.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Beyond The App Store: Europe's New Rules

Beyond The App Store: Europe's New Rules

Following regulatory pressure from the European Union, Google has revised its Play Store rules to permit alternative payment systems. This change creates a new investment opportunity in companies poised to benefit from a more open mobile app ecosystem.

View stocks
The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.